Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo et al. · The Lancet Oncology · 2014 · 4.9K citations · Full text

Medicine, Hematology, Internal Medicine +11

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva et al. · Journal of Clinical Oncology · 2015 · 2.2K citations · Full text

Medicine, Hematology, Oncology +16

Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC

Shauna M. Collins, Courtney E. Bakan, Gina D. Swartzel et al. · Cancer Immunology Immunotherapy · 2013 · 293 citations

Life Sciences, Immunology, Oncology +11

Daratumumab plus bortezomib and dexamethasone <i>versus</i> bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

Andrew Spencer, Suzanne Lentzsch, Katja Weisel et al. · Haematologica · 2018 · 262 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab

Michael S. van der Veer, Michel de Weers, Berris van Kessel et al. · Haematologica · 2010 · 217 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17